Provided by Tiger Trade Technology Pte. Ltd.

STARPHARMA HOLDINGS LTD

0.730
-0.030-3.95%
Volume:3.49M
Turnover:2.57M
Market Cap:348.25M
PE:-94.57
High:0.780
Open:0.750
Low:0.727
Close:0.760
52wk High:0.815
52wk Low:0.107
Shares:477.05M
Float Shares:347.84M
Volume Ratio:1.42
T/O Rate:1.00%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.008
EPS(LYR):-0.024
ROE:-14.47%
ROA:-7.24%
PB:16.21
PE(LYR):-30.49

Loading ...

ASX Growth Companies With High Insider Ownership To Watch

Simply Wall St.
·
May 28

ASX Growth Companies With Insider Stakes May 2026

Simply Wall St.
·
May 27

ASX Growth Stocks With High Insider Ownership To Watch

Simply Wall St.
·
May 26

Top 3 ASX Penny Stocks With Market Caps Under A$700M

Simply Wall St.
·
May 26

ASX Growth Companies With High Insider Ownership To Watch

Simply Wall St.
·
May 18

ASX Growth Leaders With Insider Stakes May 2026

Simply Wall St.
·
May 14

3 ASX Growth Stocks With High Insider Ownership And Earnings Growth Up To 124%

Simply Wall St.
·
May 13

ASX Growth Companies With High Insider Ownership In May 2026

Simply Wall St.
·
May 11

ASX's Top Growth Companies With Insider Backing May 2026

Simply Wall St.
·
May 07

ASX Growth Companies With Significant Insider Ownership

Simply Wall St.
·
May 04

ASX Growth Companies With High Insider Ownership In April 2026

Simply Wall St.
·
Apr 30

ASX Growth Leaders With High Insider Stakes

Simply Wall St.
·
Apr 28

ASX Growth Leaders With High Insider Ownership April 2026

Simply Wall St.
·
Apr 27

ASX Growth Companies With High Insider Ownership April 2026

Simply Wall St.
·
Apr 24

Starpharma Says US FDA Supports First-in-Human Study of Cancer Radiotherapy Candidate; Shares Gain 7%

MT Newswires Live
·
Apr 21

Starpharma plans first-in-human Phase 1 trial of DEP HER2 radiotherapy in Europe

Reuters
·
Apr 21

Starpharma Holdings Ltd-FDA Confirms Path to Dep Her2 First-in-Human Study

THOMSON REUTERS
·
Apr 21

Rhuroin becomes Starpharma substantial holder with 9.52% stake

Reuters
·
Apr 15

ASX Penny Stocks To Watch In April 2026

Simply Wall St.
·
Apr 08

$10,000 invested in this ASX healthcare share a year ago is now worth $36,500

MotleyFool
·
Mar 26